Engaging Thought Leadership
Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
Formulation & Delivery US 2024
16 - 17 October 2024 | San Diego, CA
Enabling the swift progression of complex, alternative drug formats to market through safe, effective & targeted formulation and delivery strategies
Formulation & Delivery US 2024
Meet Our Expert Speakers
Formulation & Delivery US 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Below are some of our featured speakers:
Jacques Van Dam
VP, Medical Affairs,
Rani Therapeutics, Inc.
Jamie Tsung
Director,
Alnylam Pharmaceuticals
Julie Zhu
Director Biopharmaceutical Product Development,
GSK
Justin Cohen
Director,
Pfizer
Lynn Kirkpatrick
Chief Executive Officer,
Ensysce Pharmaceuticals
Rachel Groppo
Director, Lead saRNA Team,
Johnson & Johnson Innovative Medicines
Robert J Duff
VP Chemistry,
Switch Therapeutics, Inc.
Ash Dugar
Chief Medical Affairs Officer,
Dyne Therapeutics
Brad Niles
Chief Executive Officer,
ARIZ Precision Medicine
CB Gurumurthy
Professor and Director,
University of Nebraska Medical Center
David Loynd
Chief Executive Officer,
EnduRx Pharmaceuticals Inc.
David M Jackson
Chief Executive Officer,
Ceria Therapeutics
David Ulkoski
Associate Director,
Korro Bio
David Slack
CEO,
Impilo Therapeutics
Deepak Sampath
Senior Vice President,
Ultragenyx
Eric Munson
Professor and Head,
Purdue University
Esmaiel Jabbari
Professor,
University of South Carolina
Evgenyi Shalaev
Distinguished Research Fellow,
Allergan
Hesong Han
Research Scientist,
UC Berkeley
Irvin Mayers
Professor,
University of Alberta
Jack Rogers
Director,
Neurochemistry at Harvard University
James Ferguson
Chief Medical Officer,
Matinas BioPharma
John Gleeson
Associate Principal Scientist,
Merck & Co.
Justin Cohen
Director,
Pfizer
Kanika Suri
Scientist,
Takeda
Kinkini Roy
Associate Director,
Aviceda Therapeutics
Laura Rotolo
Associate Scientist,
Emory university
Lenora Dieyi
Investigator,
GSK
Matt Levy
Chief Commercial Officer,
Creyon Bio
Peter Petrochenko
Associate Director,
Regeneron Pharmaceuticals
Prit Lakhani
Principal Scientist,
Bristol Myers Squibb
Rammohan Devulapally
Director,
Life Edit Therapeutics, Inc
Robert J Duff
VP Chemistry,
Switch Therapeutics, Inc.
Sean Hirschler
Principal Investigator,
GlaxoSmithKline
Severin Schneebeli
Associate Professor,
Purdue University
Sree Nadkarini
Senior Director,
Crinetics Pharmaceuticals
Vadim Klyushnichenko
VP CMC,
California Institute for Biomedical Research
Vivek Gupta
Associate Dean & Associate Professor,
St. John's University
Wenhua Wang
Senior Principal Scientist,
Regeneron
Worapol Ngamcherdtrakul
Head of Research & COO,
PDX Pharmaceuticals
Yuchen Fan
Principal Scientist,
Genentech
Yun Liu
Scientist,
Moderna Therapeutics
Zhe Wu
Principal Scientist,
Johnson & Johnson Innovative Medicine
Zhenyu Gu
Senior Director of Analytical Sciences,
Jasper Therapeutics
Meet Our Esteemed Sponsors
Gold Sponsors
Aprecia Pharmaceuticals
Gold Sponsor
Aprecia is the leader in the development and manufacturing of 3D printing (3DP) for the pharmaceutical industry. Our commercial-scale 3DP platforms and systems transform the way medicine is developed, manufactured, and delivered. We handle complex dosage forms, going beyond the limitations of traditional formulation and manufacturing methods. Applications include: ultra low-dose to ultra high-dose, fixed dose combinations, modified release, rapid orodispersibles, potent compounds, and more..
Silver Sponsors
Almac Group
Silver Sponsor
Almac Group is an established contract development and manufacturing organization providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. With over 55 years’ experience, Almac Pharma Services is an established, reliable and world leading outsourcing partner to the global pharmaceutical and biotechnology industry. Employing over 1,600 highly skilled individuals across 4 locations across the UK, Europe and the US, the company provides tailored, quality-led and timely solutions from early and late phase pharmaceutical development, clinical and commercial drug product manufacture, product launch through to commercial packaging and global distribution. Currently supporting client portfolios across more than 75 countries, the company’s fully integrated, end-to-end solutions are tailored to meet the needs of clients’ unique products and their patients.
BioDuro-Sundia
Silver Sponsor
BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for over 28 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ employees and 7 global sites across 6 cities. Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline. For more information about BioDuro-Sundia, please visit our website at www.bioduro-sundia.com
Crystal Pharmatech Inc
Silver Sponsor
Crystal Pharmatech, established in 2010, is a global company with approximately 250 employees and three R&D centers located in Suzhou (China), New Jersey (USA), and Toronto (Canada). Our key differentiator is our integrated and specialized services, including API solid-state research, crystallization, preformulation, formulation development and manufacturing, clinical supply. With an average of 20 years of experience, our scientific leadership team has successfully delivered over 100 early phase and 19 commercialized products for global pharmaceutical companies. We have served over 1,000 clients, supporting more than 2,000 new chemical entities. Leveraging our unique expertise, we collaborate with you to design and develop the most suitable crystal form and formulation for further development. Our guiding principle of "getting the crystal form and formulation right the first time for Phase I" not only expedites the progression of your molecule to IND filing and Phase I clinical trials, but also minimizes the necessity for human PK bridging studies. This approach saves valuable time and reduces costs as your program moves forward to Phase II or subsequent clinical trials.
Leukocare AG
Silver Sponsor
Leukocare AG is a leading innovator in drug product development, specializing in the stabilization and formulation of biologics across various modalities. Based in Martinsried/Munich, Germany, 50 experts tailor the services to your target product profile, ensuring optimal formulation and extended shelf life while improving logistics and reducing risks in drug development. What sets Leukocare apart is our unique integration of bioinformatics and biostatistics in the Design of Experiment (DoE), allowing us to explore a broader design space and identify the best combination of excipients. This approach combines in-silico methods with wet lab experiments, minimizing the number of required experiments and the use of drug substance, thereby accelerating development timelines. Our extensive database of over 100 regulatory-approved excipients reduces clinical hurdles, further enhancing our formulation development services. In addition, Leukocare offers comprehensive process development, analytical and bioinformatics services, supporting drug discovery and development projects up to life-cycle management with expertise in particle characterization, stability studies including prediction, and in-use studies.
Qualicaps
Silver Sponsor
Qualicaps is a global player in the manufacturing and commercialization of hard capsules and pharmaceutical processing equipment for the oral dosage market. With over 125 years of capsule manufacturing experience and the introduction of several capsule innovations to the pharmaceutical market, Qualicaps is uniquely positioned to provide an integral service to its customers through its global team of commercial, scientific, and technical experts. Since October 2023, Qualicaps has been part of Roquette, a global leader of plant-based ingredients for health and nutrition markets that operates in more than 100 countries, through more than 30 manufacturing sites, and employs around 10,000 people worldwide.
Serán BioScience, LLC
Silver Sponsor
Serán is a leading science-based CDMO that specializes in a variety of drug delivery and formulation approaches suited to optimizing bioavailability. Serán’s experienced formulation team will works with customers to identify an appropriate technology and formulation strategy to meet each program’s unique needs with a material-sparing approach. Serán provides capsules, tablets, multi-particulates, and powder-in-bottle formulations. Our solid dosage forms are engineered for a wide range of formulation approaches such as overcoming solubility challenges and to enable extended-release. We complement industry-best production practices with the finest manufacturing equipment available to produce dosage forms that perform predictably and reliably. Whether considering enabling technologies (amorphous solid dispersions, lipid formulations, particle size reduction techniques) or conventional approaches, we comprehensively assess technology options to consider bio-performance, stability, manufacturability, and drug product design – aiming to deliver you the simplest approach that meets your program’s needs.
Sever Pharma Solutions
Silver Sponsor
Sever Pharma Solutions is one of a few CDMOs specializing in controlled release systems for highly potent drugs and offering end-to-end services. We have opened up new development suites both in the US and EU to accommodate your development program for intra vaginal rings, subdermal, intra tumoral or ocular implants and aseptic fill and finish products. We can develop new products throughout the different stages of development and manufacture commercial products. We can enhance your complex pharmaceutical product by adding our high-potent drug development expertise, global GMP compliance, core capabilities, and commitment to delivering results. Book a meeting with us, you can benefit from the expertise of our experienced and knowledgeable scientists. Whether you want to discuss Hot Melt Extrusion, Polymer-based delivery systems and High-potent dosage forms, they are ready to consult you on how to make your project come alive in the best way possible. We are looking forward to discussing how our capabilities enable your next development!
XtalPi
Silver Sponsor
XtalPi is a global technology platform company powered by artificial intelligence (AI) and robotics. Founded in 2015, XtalPi is dedicated to driving intelligent and digital transformation in life sciences and discovering better therapeutics and new materials. By integrating and synergizing quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of innovative solutions, services, and products to empower our partners in the biopharmaceutical, chemical, new energy, and new materials sectors worldwide.
Bronze Sponsors
Celanese
Bronze Sponsor
The Celanese VitalDose® drug-delivery platform is an enabling technology for drug-eluting implants, inserts and transdermal films. The platform is flexible and customizable to address a variety of formulation challenges when it comes to tailoring the release rate of your drug. VitalDose® EVA is compatible with biologics and small molecules, provides reliable local or systemic drug administration, demonstrates high drug loading capacity (≤ 75%) and can be engineered for long-acting dosage profiles (zero-order or nonlinear profiles). VitalDose® EVA offers ease of formulation and is configurable into a variety of geometries. With long clinical use history and an established regulatory path, Celanese is able to address challenges with a proven platform for effective delivery of molecules at both a systemic and localized level. From feasibility to development to commercialization, our scientists and engineers are with you from concept to commercialization, providing development services, material supply aligned with GMP principles and regulatory support.
NOF CORPORATION
Bronze Sponsor
NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's lipid nanoparticle platform for nucleic acid delivery composed of COASOMEⓇ SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF LNP platform is becoming adopted in clinical planning by NOF collaborators.
Pfanstiehl
Bronze Sponsor
Pfanstiehl is globally recognized as a leader in manufacturing cGMP high-purity, low-endotoxin, low-metal injectable-grade excipients and biopharmaceutical components for various applications in bioprocessing, formulation, and specialty areas. Additionally, Pfanstiehl operates as a prominent contract development and manufacturing organization (CDMO), specializing in the isolation, purification, custom synthesis, and scale-up development of small molecule Active Pharmaceutical Ingredients (APIs) ranging from gram to multi-ton commercial quantities. While many ingredient manufacturers or resellers cater to various industries like food, cosmetics, agriculture, and nutritional supplements, providing only a limited range of “pharma-grade” ingredients, Pfanstiehl’s exclusive focus lies in Biopharma applications.
Syngene International Ltd
Bronze Sponsor
Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's more than 5000 scientists offer both skills and the capacity to deliver great science, robust data security, and world-class manufacturing at speed to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2.2 Mn sq. ft of specialist facilities, Syngene works with biotech companies pursuing leading-edge science, such as GSK, Zoetis, and Merck KGaA.
Unchained Labs Ltd
Bronze Sponsor
Here’s the deal. We’re all about helping biologics and gene therapy researchers break free from tools that just don’t cut it. Unleashing problem-tackling solutions that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.
Network & Programme Sponsors
Catalent
Network & Programme Sponsor
Catalent Inhalation has the capabilities, expertise and state-of-the-art facilities to expedite product development, from concept and feasibility studies through commercial manufacture and release testing. With over 30 years of inhalation product experience, Catalent can handle the most complex projects and help bring your therapy to market, faster. Whether a single service or a comprehensive development package is required, Catalent offers end-to-end solutions for pulmonary and nasal delivery, with development and manufacturing capabilities for Dry Powder Inhalers, unit-dose, bi-dose and multi-dose nasal products. In addition, Catalent provides comprehensive analytical, bioanalytical and clinical supply services to support your molecule from development through product launch and beyond.
Corealis Pharma
Network & Programme Sponsor
Corealis offers complete formulation development and clinical supply manufacture of pharmaceutical oral solid dosage forms for US, European, and Canadian submissions. Each project is different and Corealis experts select the most suitable formulation and manufacturing process train for each drug substance as per its intended application. They have in-house access to well-equipped, state-of-the-art R&D and GMP-compliant operations such as API characterization, spray drying, hot melt extrusion, solid dispersion, high shear granulation, fluid-bed granulation/ drying/ coating, roller compaction, melt granulation, extrusion/spheronization, pan coating, tableting, encapsulation, packaging, patient kits preparation, warehousing, distribution, and analytical services. This means that when Corealis professionals commit to a delivery date and budget, they have all the tools and resources needed to stand by their commitments and the ability to adjust quickly to any changes that may occur in the execution of a project.
MilliporeSigma
Network & Programme Sponsor
MilliporeSigma, a life science leader, is a business of Merck KGaA, Darmstadt, Germany. We provide excipients, APIs, critical raw materials as well as contract testing, development and manufacturing services to support all stages of your drug manufacturing process. Additionally, our products and services include single-use manufacturing, filtration, process development, application services and biosafety testing services. Our portfolio of excipients meets the highest quality and purity standards and comes with extensive documentation. It offers a variety of functionalities and solutions for formulation challenges of small and large molecules such as solubility enhancement, viscosity reduction, controlled release, and stabilization of the active ingredient. As we take pride in supporting our customers beyond supply, our experienced and responsive team of raw material and regulatory experts are committed to understand your requirements and provide tailored solutions that meet your exact needs.
Onyx Scientific Limited
Network & Programme Sponsor
Onyx Scientific is the CDMO division of IPCA Laboratories. Our MHRA-licensed sites in the UK specialises in offering an integrated solid form, preformulation, crystallisation and chemical development services that facilitate the manufacture of candidate APIs for clinical phases through to commercial supply. Our dedicated teams are available to provide bespoke, independent, outsourced solid form projects to complement or support your in-house campaigns in addition to our integrated CMC full-service. With a wealth of early phase development experience and success, our phase appropriate, fit-for-purpose approach focuses on rapid process development with a view to future GMP campaigns. Where required, scale-up through Phase II towards commercial manufacture is retained either at Onyx or within the Group through an in-house transfer to our sister sites and colleagues in the USA and India.
Phosphorex
Network & Programme Sponsor
Phosphorex is a leading provider of drug delivery technologies and solutions. By harnessing the potential of microspheres and nanoparticles for drug delivery, Phosphorex offers tailored solutions and enabling technologies to optimize a drug's release rate, targeting ability, bioavailability, and deliverability, with the goal of achieving desired therapeutic effects while reducing adverse clinical outcomes. Phosphorex supports pharmaceutical and biotech companies through all phases of their development, from proof of concept to clinical studies and will offer cGMP manufacturing services in 2025. Phosphorex's mission is to help our partners solve complex problems and develop successful drugs to help patients. Additional information about Phosphorex is available at www.phosphorex.com or follow us on LinkedIn.
SGS VITROLOGY LIMITED
Network & Programme Sponsor
With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products. SGS provides a comprehensive range of biosafety services such as: virology, cell and molecular biology, microbiology and TEM. Health Authorities (US FDA and the EMA), require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses and other potential contaminants. SGS ensures product safety in satisfying these regulatory requirements.
WuXi STA
Network & Programme Sponsor
WuXi STA, an integrated part of WuXi AppTec, is an industry-leading pharmaceutical development and manufacturing capability and technology platform serving the life sciences industry with operations across North America, Europe and Asia. As an innovative Contract Development, and Manufacturing Organization (CDMO) for small molecule new drug development, WuXi STA offers our worldwide partners efficient, flexible, and high-quality solutions from preclinical to commercial uses.
The Future of Sustainable Drug Delivery: Bacterial Cellulose Nanoparticles
Recent research examines the potential application of bacterial cellulose nanoparticles as a sustainable drug delivery method.
Exolvo Biosciences' Approach to Advancing Oral Biologics Drug Delivery
NLC Health Ventures collaborates with Verily, a precision health tech company, to launch Exolvo Biosciences: an up-and-coming biotech delivering next generation solution for biologics drug delivery.
CRISPR 2.0 - Improving Drug Delivery Through Ultracompact CRISPR Systems
New genome editing methods are building on the capabilities of CRISPR/Cas9. The CasMINI is the latest technology that aims to safely and efficiently deliver genetic therapies to patients.
Enhancing Drug Stability & Exploring Novel Formulation Strategies
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Formulation & Delivery UK 2024
Innovative Foam Technology Enhances Gene Therapy Delivery
Researchers at the Fred Hutch Cancer Center conducted a study investigating the potential of medicated foam as a gene therapy delivery vector. Their studies showed that a foam-based delivery system enhances the efficiency and safety of gene therapy by ensuring concentrated, controlled release of therapeutic agents.
Freeze-Drying 2.0: Examining the Potential of Thin Film Freezing
TFF Pharmaceuticals and the Cleveland Clinic team up to advance multivalent influenza vaccine candidates into preclinical phases.
DoubleTree by Hilton Hotel San Diego - Mission Valley
7450 Hazard Center Dr, San Diego, CA 92108
By Trolley
The closest Trolley stop to the hotel is Hazard Center Station – this stop is served by the Sycuan Green Line. The hotel is a 7 mins walk from the station. When alighting at this stop, walk north on Hazard Center East Driveway towards Hazard Center Drive. Then turn left and the hotel will be on your right.
By Car
There is self-parking available (garage parking) at the hotel for $34 (this may be subject to state local taxes). There is no valet parking at this venue. For further information please contact the hotel directly. For driving instructions and a map, please click here
By Air
San Diego International Airport – The DoubleTree by Hilton San Diego – Mission Valley is 7 miles from the International Airport. A single taxi ride to the hotel will cost approx. $40 and will take around 20 minutes. Transportation to/from the hotel is provided by Super Shuttle, Cloud 9, or other shuttle services for approx. $10-$15 per person. Please click here for more information on travelling to the hotel from the airport.
By Bus
The closest bus stop to the venue is Camino De La Reina & Mission Center Rd, which is a 13min walk away. When alighting at this stop, walk north on Mission Center Rd towards Camino De La Reina. Turn left onto Hazard Center Dr and then right on to Frazee Rd – the hotel should be on the right hand side. Please click here for more information on Trolley and bus services in the area.
Oxford Global has secured a number of bedrooms at the Doubletree by Hilton San Diego Mission Valley at a reduced conference rate:
- Tuesday 15th October 2024 – $265 (includes room rate, taxes & daily continental breakfast)
- Wednesday 16th October 2024 – $265 (includes room rate, taxes & daily continental breakfast)
Should you wish to book a room, please click here.
The final cut-off date to book bedrooms is Friday 20th September 2024 – any bookings after this date are subject to availability and rates. Please note, that any cancellations within 14 days prior to arrival are subject to cancellation charges.
Additionally, we kindly remind all attendees to only book their accommodation if they are registered for the event. This ensures that accommodations are available for those who have officially secured their attendance.
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Formulation & Delivery US 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.
